MediumCardiologyHeart failure with reduced ejection fractionau-amcau-racp
A 68-year-old man with a history of prior NSTEMI and heart failure with reduced ejection fraction (LVEF 30%) is stable in clinic. He is currently taking perindopril, bisoprolol and low-dose aspirin. His blood pressure is 120/70 mmHg, heart rate 64 beats/min. According to contemporary heart failure guidelines, which additional medication has the greatest evidence for further reducing mortality and heart failure hospitalisation?